ANG Lifesciences India Balance Sheet Annual

Trade

BSE: 540694 | NSE: - | ISIN: INE236W01016 | Sector: Biotechnology & Drugs

45.00 0.00 (0.00%)Updated : 27 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	5.42	5.85	6.31	-
Cash Equivalents	0.32	0.32	0.35	3.86
Short Term Investments	11.58	12.35	11.69	-
Cashand Short Term Investments	17.32	18.52	18.34	3.86
Accounts Receivable- Trade Net	73.28	83.15	102.06	58.74
Total Receivables Net	73.28	112.28	102.06	81.96
Total Inventory	47.77	54.02	36.96	19.26
Other Current Assets Total	40.58	1.73	35.46	10.79
Total Current Assets	178.94	186.89	192.81	115.87
Property/ Plant/ Equipment Total- Net	58.40	88.15	92.61	23.86
Long Term Investments	0.24	0.15	1.03	3.52
Note Receivable- Long Term	0.11	0.39	-	-
Other Long Term Assets Total	4.75	4.12	4.58	0.17
Total Assets	242.44	279.70	291.03	143.65
Accounts Payable	66.18	83.34	70.63	40.04
Current Portof LT Debt/ Capital Leases	56.11	5.02	8.77	3.19
Other Currentliabilities Total	22.27	28.93	40.30	15.39
Total Current Liabilities	144.57	162.28	166.29	91.56
Long Term Debt	13.95	20.54	21.64	2.33
Capital Lease Obligations	2.77	2.31	-	4.70
Total Long Term Debt	16.72	22.84	21.64	7.03
Total Debt	72.84	72.79	77.00	43.16
Deferred Income Tax	1.33	1.49	0.62	0.24
Other Liabilities Total	3.54	6.87	18.72	3.24
Total Liabilities	166.16	193.49	207.26	102.07
Common Stock Total	13.06	13.06	10.37	5.18
Retained Earnings( Accumulated Deficit)	63.22	62.85	73.40	36.40
Total Equity	76.28	86.22	83.77	41.58
Total Liabilities Shareholders' Equity	242.44	279.70	291.03	143.65
Total Common Shares Outstanding	1.31	1.31	1.30	1.30
Tangible Book Valueper Share Common Eq	58.41	66.03	64.65	31.91
Prepaid Expenses	-	0.34	-	-
Property/ Plant/ Equipment Total- Gross	-	146.87	-	-
Accumulated Depreciation Total	-	-58.71	-	-
Accrued Expenses	-	0.06	-	-
Notes Payable/ Short Term Debt	-	44.93	46.58	32.94
Additional Paid- In Capital	-	5.62	-	-
Other Equity Total	-	4.69	-	-
Intangibles Net	-	-	-	0.23